Page last updated: 2024-12-08

paraherquamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

paraherquamide: structure very similar to marcfortine A; RN given refers to the (1'alpha,5'abeta,7'beta,8'abeta,9'abeta)-isomer; RN for cpd without isomeric designation not avail 6/90 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID156934
SCHEMBL ID1547700
MeSH IDM0176432

Synonyms (17)

Synonym
paraherquamide
(-)-paraherquamide
brn 3599562
(-)-paraherquamide a
r72vb4e4kc ,
unii-r72vb4e4kc
77392-58-6
(1'r,5'as,7'r,8'as,9'ar)-2',3',8'a,9'-tetrahydro-1'-hydroxy-1',4,4,8',8',11'-hexamethylspiro(4h,8h-(1,4)dioxepino(2,3-g)indole-8,7'(8'h)-(5h,6h-5a,9a)(iminomethano)(1h)cyclopent(f)indolizine)-9,10'(10h)-dione
paraherquamide [mi]
SCHEMBL1547700
(1's,6'r,7'r,8r,9's)-6'-hydroxy-4,4,6',10',10',13'-hexamethylspiro[10h-[1,4]dioxepino[2,3-g]indole-8,11'-3,13-diazatetracyclo[5.5.2.01,9.03,7]tetradecane]-9,14'-dione
nsc-784317
nsc784317
Q27287870
DTXSID70998607
1',9-dihydroxy-1',4,4,8',8',11'-hexamethyl-2',3',8'a,9'-tetrahydro-1'h,4h,5'h,6'h,8'h-spiro[1,4-dioxepino[2,3-g]indole-8,7'-[5a,9a](epiminomethano)cyclopenta[f]indolizin]-10'-one
AT37274

Research Excerpts

Overview

Paraherquamide is a novel natural anthelmintic product with a mode of action that is incompletely characterized.

ExcerptReferenceRelevance
"Paraherquamide is a novel natural anthelmintic product with a mode of action that is incompletely characterized. "( Paraherquamide and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in Ascaris muscle.
Burns, TA; Clark, CL; Geary, TG; Martin, RJ; Robertson, AP; Thompson, DP; Trailovic, SM, 2002
)
3.2

Toxicity

ExcerptReferenceRelevance
" In initial trials, it had an excellent safety profile in cattle and sheep at doses efficacious against a dozen or more helminths, but recently it produced unexpected and severe toxicosis in dogs at doses far below those that were safe in the ruminants."( Acute toxicity of paraherquamide and its potential as an anthelmintic.
Eary, CH; Haines, HW; Michael, BF; Shoop, WL, 1992
)
0.62

Dosage Studied

ExcerptRelevanceReference
" Cooperia punctata, the dosage-limiting species, was virtually unaffected by any dosage except the highest, which produced an efficacy of 89%."( Anthelmintic activity of paraherquamide in calves.
Eary, CH; Haines, HW; Michael, BF; Shoop, WL, 1992
)
0.59
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's14 (41.18)18.2507
2000's17 (50.00)29.6817
2010's1 (2.94)24.3611
2020's2 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.58 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index4.49 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews6 (17.65%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (82.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]